A single blood test finds more early cancers than Britain's screening programs combined in a trial

Data presented at ASCO show Galleri detected more early-stage cancers than all existing UK screening programs combined and sharply increased diagnoses in a US real-world study; researchers stress it does not replace standard screening and survival benefits remain unproven.